Literature DB >> 10235505

Fatal pulmonary tumor embolism caused by chondroblastic osteosarcoma: report of a case and review of the literature.

A A Ahmed1, D S Heller.   

Abstract

Fatal pulmonary tumor embolism is an unusual phenomenon that has only rarely been reported with osteosarcoma. It usually presents with typical symptoms and signs of pulmonary thromboembolism. The authors report the case of a 65-year-old woman with chondroblastic osteosarcoma of the distal femur who suffered a fatal tumor embolism 30 hours after surgery and review the literature.

Entities:  

Mesh:

Year:  1999        PMID: 10235505     DOI: 10.5858/1999-123-0437-FPTECB

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Transtumoral plating as a novel method for palliative limb spare and thromboembolism in a dog with a distal radial primary bone tumor.

Authors:  Sarah E Boston; Maureen Barry; M Lynne O'Sullivan
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

Review 2.  Osteosarcoma tumor thrombus: a case report with a review of the literature.

Authors:  Pournima Navalkele; Sarah M Jones; Jason K Jones; Jorge D Salazar; Patrick C Toy; Rathi V Iyer; Betty Herrington
Journal:  Tex Heart Inst J       Date:  2013

Review 3.  Inferior vena cava extension of pelvic osteogenic sarcoma.

Authors:  Alexandre Arkader; Carol D Morris
Journal:  Cancer Imaging       Date:  2008-01-23       Impact factor: 3.909

Review 4.  Pulmonary tumor embolism secondary to soft tissue and bone sarcomas: a case report and literature review.

Authors:  Nicholas Latchana; Vincent C Daniel; Robert W Gould; Raphael E Pollock
Journal:  World J Surg Oncol       Date:  2017-08-30       Impact factor: 2.754

5.  Radiological characteristics and predisposing factors of venous tumor thrombus in pelvic osteosarcoma: A mono-institutional retrospective study of 115 cases.

Authors:  Haijie Liang; Wei Guo; Rongli Yang; Xiaodong Tang; Taiqiang Yan; Tao Ji; Yi Yang; Dasen Li; Lu Xie; Jie Xu
Journal:  Cancer Med       Date:  2018-08-23       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.